fbpx
January 18, 2023

CDC Appoints New Second in Command CDC Appoints New Second in Command

Nirav Shah, MD, JD, the current director of the Maine Center for Disease Control and Prevention, will join the national Centers for Disease Control and Prevention […]
January 18, 2023

Children and COVID: ED Visits and Hospitalizations Start to Fall Children and COVID: ED Visits and Hospitalizations Start to Fall

Emergency department visits and hospitalizations for COVID-19 in children appear to be following the declining trend set by weekly cases since early December, based on data […]
January 18, 2023

Drugs Advertised on TV Aren’t Better Than Existing Options: Study Drugs Advertised on TV Aren’t Better Than Existing Options: Study

Most drugs advertised on television don’t work better than existing alternatives, a new analysis shows. And manufacturers spend more on advertising for those less beneficial drugs […]
January 18, 2023

Can ‘Radical Rest’ Help With Long COVID Symptoms? Can ‘Radical Rest’ Help With Long COVID Symptoms?

Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. On March 18, 2020, Megan Fitzgerald was lying on the […]
January 18, 2023

Paxlovid Prescribing Concerns Seen in Practitioner Survey Paxlovid Prescribing Concerns Seen in Practitioner Survey

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Concerns over drug interactions, existing health conditions and, to a lesser extent, […]
January 18, 2023

Evolocumab’s LDL Lowering Surpassed Inclisiran’s in ORION-3 Evolocumab’s LDL Lowering Surpassed Inclisiran’s in ORION-3

Patients who received an injection of inclisiran (Leqvio), a small interfering RNA (siRNA) agent, every 6 months for as long as 4 years safely maintained about a 45% […]
January 18, 2023

Residual Beta-Cell Function May Protect Kidneys in Type 1 Diabetes Residual Beta-Cell Function May Protect Kidneys in Type 1 Diabetes

The study covered in this summary was published in Research Square as a preprint and has not yet been peer reviewed. Key Takeaways Nearly two thirds of […]
January 18, 2023

Fewer Patients With Diabetes Meeting Treatment Targets Fewer Patients With Diabetes Meeting Treatment Targets

Fewer patients with type 2 diabetes in Canada are achieving target numbers for blood pressure, statin use, and use of other important medications, according to a […]
January 18, 2023

Ultralow Dose of Nivolumab Offers Huge Cost Savings Ultralow Dose of Nivolumab Offers Huge Cost Savings

A randomized clinical trial from India raises the possibility of huge cost savings by using much lower doses of immunotherapy. The researchers used just 6% of […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977978979980981982983984985986987988989990991992993994995996997998999100010011002100310041005100610071008100910101011101210131014101510161017101810191020102110221023102410251026102710281029103010311032103310341035103610371038103910401041104210431044104510461047104810491050105110521053105410551056105710581059106010611062106310641065106610671068106910701071107210731074107510761077107810791080108110821083108410851086108710881089109010911092109310941095109610971098109911001101110211031104110511061107110811091110111111121113111411151116
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0